The four-year strategic partnership will give Bupa’s UK health insurance customers access to Spire Healthcare facilities.
Bupa UK insurance and Spire Healthcare have signed a four-year strategic partnership agreement, under which Spire will provide care to Bupa’s UK health insurance customers, including access to eight existing cancer specialist centres across the UK.
Within the agreement, there is also a commitment to expanding oncology and musculoskeletal (MSK) patient pathways, including adding five new Bupa cancer specialist centres to the network and five new MSK rapid-access pathway sites. In addition, a new gynaecology specialist centre will be launched as part of the extended network.
The two companies have said that they will also work together and share data to develop a value-based healthcare approach and drive clinical care excellence, as well as collaborate across the sector to achieve net-zero ambitions.
“Over the next four years, we’ll keep pushing the boundaries of what great healthcare looks like, making it quicker and simpler for people to get the diagnosis and treatment they need,” said Nikola Kamel, head of hospital management at Bupa UK insurance.
Spire Healthcare currently has five breast cancer specialist centres in Bristol, Bushey (Watford), Edinburgh, Little Aston (Birmingham), and Southampton. It has two prostate cancer specialist centres in Bushey and Solihull (Birmingham), and one bowel cancer specialist centre in Portsmouth.
Bupa, Spire and Vita Health (part of Spire Healthcare Group) developed an initiative to provide rapid access to musculoskeletal (MSK) services, to offer triage within 24 hours and imaging where required within three working days, currently being piloted across six Spire sites across the country.
